These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Comparison of Efficacy and Safety Between Propranolol and Steroid for Infantile Hemangioma: A Randomized Clinical Trial. Kim KH, Choi TH, Choi Y, Park YW, Hong KY, Kim DY, Choe YS, Lee H, Cheon JE, Park JB, Park KD, Kang HJ, Shin HY, Jeong JH. JAMA Dermatol; 2017 Jun 01; 153(6):529-536. PubMed ID: 28423174 [Abstract] [Full Text] [Related]
8. The Role of the Pharmacist in the Treatment of Patients with Infantile Hemangioma Using Propranolol. Castaneda S, Melendez-Lopez S, Garcia E, De la Cruz H, Sanchez-Palacio J. Adv Ther; 2016 Oct 01; 33(10):1831-1839. PubMed ID: 27461120 [Abstract] [Full Text] [Related]
9. Propranolol vs prednisolone for symptomatic proliferating infantile hemangiomas: a randomized clinical trial. Bauman NM, McCarter RJ, Guzzetta PC, Shin JJ, Oh AK, Preciado DA, He J, Greene EA, Puttgen KB. JAMA Otolaryngol Head Neck Surg; 2014 Apr 01; 140(4):323-30. PubMed ID: 24526257 [Abstract] [Full Text] [Related]
10. Clinical features of cutaneous infantile hemangioma combined with asymptomatic infantile hepatic hemangioma and efficacy of propranolol treatment. Li L, Yu L, Xu Z, Wei L, Zhang B, Han X, Sun Y, Ma L. J Cosmet Dermatol; 2023 Dec 01; 22(12):3369-3374. PubMed ID: 37313653 [Abstract] [Full Text] [Related]
12. Use of the Hemangioma Severity Scale to facilitate treatment decisions for infantile hemangiomas. Moyakine AV, Herwegen B, van der Vleuten CJM. J Am Acad Dermatol; 2017 Nov 01; 77(5):868-873. PubMed ID: 28818436 [Abstract] [Full Text] [Related]
13. Clinical and economic impact of surgery for treating infantile hemangiomas in the era of propranolol: overview of single-center experience from La Paz Hospital, Madrid. López-Gutiérrez JC. Eur J Pediatr; 2019 Jan 01; 178(1):1-6. PubMed ID: 30421264 [Abstract] [Full Text] [Related]
14. Symplastic hemangioma developing over an infantile hemangioma during propranolol treatment. Downey C, Pino G, Zambrano MJ, Kramer D, Cervilla K, González S. Pediatr Dermatol; 2019 Nov 01; 36(6):961-962. PubMed ID: 31468563 [Abstract] [Full Text] [Related]
15. Propranolol for infantile hemangiomas in developing countries. McMichael J, Lawley LP. Dermatol Online J; 2017 Mar 15; 23(3):. PubMed ID: 28329512 [Abstract] [Full Text] [Related]
16. Efficacy of propranolol in hepatic infantile hemangiomas with diffuse neonatal hemangiomatosis. Mazereeuw-Hautier J, Hoeger PH, Benlahrech S, Ammour A, Broue P, Vial J, Ohanessian G, Léauté-Labrèze C, Labenne M, Vabres P, Rössler J, Bodemer C. J Pediatr; 2010 Aug 15; 157(2):340-2. PubMed ID: 20488455 [Abstract] [Full Text] [Related]
17. Effectiveness of propranolol in the treatment of infantile hemangioma beyond the proliferation phase. Vivas-Colmenares GV, Bernabeu-Wittel J, Alonso-Arroyo V, Matute de Cardenas JA, Fernandez-Pineda I. Pediatr Dermatol; 2015 Aug 15; 32(3):348-52. PubMed ID: 25721095 [Abstract] [Full Text] [Related]
18. Clinical and radiological outcomes of infantile hemangioma treated with oral propranolol: A long-term follow-up study. Yu Z, Cai R, Chang L, Qiu Y, Chen X, Chen Q, Ma G, Jin Y, Lin X. J Dermatol; 2019 May 15; 46(5):376-382. PubMed ID: 30916822 [Abstract] [Full Text] [Related]